Market
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific announced a $1.5 billion investment to acquire a 34% equity stake in MiRus, a developer of implants and procedural solutions. The investment underscores Boston Scientific's strategy to expand its portfolio in implantable devices and minimally invasive procedural technologies.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network